Literature DB >> 23381818

Effect of nitrofen in the final stages of development of the diaphragm muscle in rats.

Frances Lilian Lanhellas Gonçalves1, Fábio Santana de Oliveira, Augusto Frederico Schmidt, Luís Antônio Violin Dias Pereira, Rodrigo Melo Gallindo, Rebeca Lopes Figueira, Lourenço Sbragia.   

Abstract

PURPOSE: To evaluate the expression of myosin in muscle fibers of the diaphragm in experimental congenital diaphragmatic hernia (CDH).
METHODS: Fetuses of pregnant rats were divided into four groups: External Control (EC), composed of non-manipulated rats; Nitrofen, composed of pregnant rats that received 100 mg of nitrofen (2,4-dichloro-4'nitrodiphenyl ether) diluted in olive oil on gestational day (GD) 9.5, whose fetuses developed CDH (N+) or not (N-), and Olive Oil Placebo (OO), composed of pregnant rats that received the oil on the same GD. The fetuses were collected on GD 18.5, 19.5, 20.5 and 21.5 (term = 22 days). We obtained body weight (BW) and photographed the diaphragm area (DA), hernia area (HA) and subsequent calculated the HA/DA ratio in N+ group. Samples of Diaphragm muscle were processed for histological staining with H/E and immunohistochemistry (IHQ) for myosin.
RESULTS: The fetuses of N- and N+ groups had decreased BW and DA compared to EC and OO groups (p < 0.001). HA was decreased on GD 18.5 compared to 21.5 (p < 0.001) and the HA/DA ratio showed no difference. IHQ showed decreased expression of myosin in nitrofen groups.
CONCLUSION: CDH induced by nitrofen model contributes to the understanding of muscularization in the formation of the diaphragm where the myosin expression is decreased.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23381818     DOI: 10.1590/s0102-86502013001300004

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  Myogenin gene expression is not altered in the developing diaphragm of nitrofen-induced congenital diaphragmatic hernia.

Authors:  Toshiaki Takahashi; Florian Friedmacher; Hiromizu Takahashi; Alejandro Daniel Hofmann; Prem Puri
Journal:  Pediatr Surg Int       Date:  2014-07-24       Impact factor: 1.827

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.